Dr Amol Akhade (@suyogcancer) 's Twitter Profile
Dr Amol Akhade

@suyogcancer

Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists

ID: 1135941148378247168

linkhttp://suyogcancerclincs.com calendar_today04-06-2019 16:07:29

7,7K Tweet

6,6K Takipçi

132 Takip Edilen

Dr Amol Akhade (@suyogcancer) 's Twitter Profile Photo
Dr Amol Akhade
@suyogcancer

4 months ago

Antibody–Drug Conjugates (ADCs) in SCLC All active agents in 2L/3L+ setting—DLL3, B7-H3, SEZ6, TROP2—summarized in one slide. Includes payloads, companies,trials, ORR/PFS/OS, and toxicity profile Which one you think is most promising one #OncoTwitter OncoAlert Yakup Ergün

Antibody–Drug Conjugates (ADCs) in SCLC All active agents in 2L/3L+ setting—DLL3, B7-H3, SEZ6, TROP2—summarized in one slide. Includes payloads, companies,trials, ORR/PFS/OS, and toxicity profile Which one you think is most promising one #OncoTwitter <a href="/OncoAlert/">OncoAlert</a> <a href="/dr_yakupergun/">Yakup Ergün</a>